GKOS Glaukos Corporation: Earnings growth forecast for next year

GKOS (Glaukos Corporation) - company brandmark

Steady demand for glaucoma treatment driven by an aging population has ensured confident growth, and the expected net income change metric has reached a peak. Currently, 107.90 records a new level mark. Glaukos Corporation (GKOS) is investing in drug delivery systems and implants, maintaining its scientific priority. Despite a narrow specialization in microsurgery, the company is successfully expanding its therapeutic platforms.

Glaukos Corp (GKOS): Net earnings per share growth forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Glaukos Corp (GKOS)

- price and consensus price forecast:
Basic company analysis:GKOS, Glaukos Corp
Brand item of Glaukos

This indicator measures the analysts' consensus forecast for earnings growth rates in the coming period, identifying the gap between market optimism and actual fundamental stability. The fact that Glaukos Corporation (GKOS) is operating its production capacities at full limit creates a risk of failing to meet these expectations; therefore, the projection of the company's earnings dynamics for the next year serves as a signal for a potential capital revaluation should any operational disruptions occur.

Competitors of Glaukos Corporation

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year APLS|Net earnings per share growth forecast for next year BLTE (Belite Bio Inc)|Earnings growth forecast for next year OCUL (Ocular Pharma)|Earnings growth forecast for next year Harrow Corp HROW|VRDN - Net earnings per share growth forecast for next year|LENZ (LENZ Therapeutics) - Projected earnings per share growth rate for next year|Oculis (OCS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year EYPT (EyePoint Pharmaceuticals Inc)|Net earnings per share growth forecast for next year Kodiak Sciences Inc|Expected net earnings per share growth next year aldeyra.com ALDX|Earnings growth forecast for next year KALA|IRD - Expected net earnings per share growth next year|Earnings growth forecast for next year OKYO (OKYO Pharma Limited)|ADVM - Expected earnings per share growth for next year|OTLK: Expected earnings per share growth for next year|CLSD (Clearside) - Projected earnings per share growth rate for next year|NBY: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)